Disease Treat

Know About Ulcers Blog

12th International Symposium of Gastroenterology 2018


Ladies and gentleman, I’m honoured to welcome you all to the 12th International Symposium of Gastroenterology here in Bratislava, the capital of Slovakia. Since we were the creators of the programme, the topics were known to me. The presenters had freedom to cover the topics, so there was a lot of new information in each of the lectures. The dominant topic that opened the symposium was non-alcoholic liver disease. I think that we will likely encounter this illness more and more often in the future. These types of meetings are extremely useful. They are very well focused around hot topics in liver and gastrointestinal diseases and I particularly enjoyed the session on NAFLD. There will be another session on the microbiome, which is something people need to be familiar with because it will bring a lot of new knowledge in the future – so better start now. There are also some hot topics in inflammatory bowel disease. Future gastroenterology, yes, the microbiome is one page we’ve started to open these past days, and I think it’s a very interesting continuation of this topic. The programme does cover absolutely fundamental topics, from liver transplants to treatment of hepatitis, the microbiome, the consequences of obesity – i.e., fatty liver. I held a talk on the metabolic effects of bile acids, which is a relatively novel topic. I will talk about the prevention of acute pancreatitis, which I think is a very important topic. I presented a paper on the impact of bariatric metabolic surgery on patients with NAFLD and non-alcoholic steatohepatitis. I really enjoyed today’s talk about microbiota and yesterday’s lecture on osteopontin in the diagnostic treatment of portal hypertension. If we can, we’ll have a discussion backstage and exchange contacts. At the conference I spoke on faecal microbial transplants, which is a new method that has recently gained general acceptance in the treatment of recurring and refractory Clostridium infections and ulcerative colitis. NAFLD is a very serious issue in the current stage of medical developments. It is current not only for hepatologists, but rather it is a multidisciplinary problem. I like this symposium very much. It shows just the beginning probably of collaboration between different specialists. I wish to continue these very useful and interesting meetings. The scientific programme of 12th International Symposium of Gastroenterology is done.

Leave a Reply

Your email address will not be published. Required fields are marked *